Laboratory of Sports Medicine
Thessaloniki, 546 35, Greece
NCT Number: NCT03304483
The aim of this study is to examine the cardiovascular effects of ultramarathon running and their relation to performance.
Looking for future studies?
Notify Me18 year–67 year
All sexes
Interventional
Not applicable
Thessaloniki, 546 35, Greece
The purpose of the study is to determine the changes of cardiovascular morphology and function after an ultramarathon race. 50 entrants to the "Spartathlon 2017" 246-km running race will participate in the study. Cardiac and arterial morphology and function tests will be conducted one day before the race and within 20 minutes of race completion.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Spartathlon 2017
Time frame: before and after 1 day running
Echocardiographic study of left ventricular function
Time frame: before and after 1 day running
Echocardiographic study of left ventricular function
Time frame: before and after 1 day running
Echocardiographic study of carotid arteries
Aristotle University Of Thessaloniki
Other
Cardiovascular Effects of Ultramarathon Running
Acronym: Spartathlon
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT07725445
Arrhythmias, Cardiac, Cardiac Arrhythmias
Seoul, South Korea
View Trial DetailsNCT07736066
Cardiac Rehabilitation, Cardiac Surgery
Seoul, South Korea
View Trial DetailsNCT01952171
Cardiovascular Abnormalities, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial Details